Literature DB >> 22228091

Risk factors for distal Contegra stenosis: results of a prospective European multicentre study.

Dietmar Boethig1, Christian Schreiber, Mark Hazekamp, Ute Blanz, Rene Prêtre, Boulos Asfour, Ruben Greco, Vladimir Alexi-Meskishvili, Arturo Gonçalves, Thomas Breymann.   

Abstract

Objectives The EUCon study was designed to identify risk factors for distal anastomotic stenosis after bovine jugular vein (Contegra) implantation in children. Methods Between March 2006 and August 2008, 104 devices were implanted in nine European centers. Preoperative, intraoperative, and follow-up data (at discharge, 6, 12, 24 months) including standardized echocardiography were prospectively registered, source data verified and collected in a central database. Main endpoint was distal stenosis (either postvalvular gradient of ≥50 mm Hg or need for intervention for distal stenosis). Eight potential risk factors (age <2 years, diagnosis, running suture, use of glue, flapless anastomosis, oversizing less than + 2 z, anticoagulation, implantation site) were investigated. Cox regression, decision tree analyses, and "Clustering by Response" were applied. Results Patient age ranged from 0 to18 years, mean 6.0 ± 6.1, median 3.2 years. Implantation reasons: 88% congenital malformations, 12% Ross operations. Follow-up was 88.3% complete. Durability (freedom from death, reoperation, degeneration, endocarditis, and explantation) compared well to corresponding homograft literature. Sixteen patients reached study endpoints. Age <2 years was the only invariably significant risk factor (p = 0.044); "Clustering By Response" found young anticoagulated patients with oversized conduits to be at a higher risk than the others (p = 0.018, OR = 3.2). Conclusion Patient age is the main risk factor for development of distal anastomosis stenosis after Contegra implantation. The influence of the other investigated factors is too small to be proven in 104 patients after 2 years, or other risk factors must be taken into consideration to explain outcome differences among recipients under 2 years. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2012        PMID: 22228091     DOI: 10.1055/s-0031-1298062

Source DB:  PubMed          Journal:  Thorac Cardiovasc Surg        ISSN: 0171-6425            Impact factor:   1.827


  5 in total

1.  Use of oversized injectable valves in growing children for total repair of right ventricular outflow tract anomalies (preliminary results).

Authors:  Luca Deorsola; Pietro Angelo Abbruzzese
Journal:  Tex Heart Inst J       Date:  2014-08-01

2.  Mid-term outcomes of Contegra implantation for the reconstruction of the right ventricular outflow tract to proximal branch pulmonary arteries: Japan multicentre study.

Authors:  Takaya Hoashi; Hajime Ichikawa; Keiichi Hirose; Naohiro Horio; Takahisa Sakurai; Hironori Matsuhisa; Yoshihiro Ohsima; Hajime Sakurai; Shingo Kasahara; Kisaburo Sakamoto
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

3.  Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience.

Authors:  Samir Sarikouch; Alexander Horke; Igor Tudorache; Philipp Beerbaum; Mechthild Westhoff-Bleck; Dietmar Boethig; Oleg Repin; Liviu Maniuc; Anatol Ciubotaru; Axel Haverich; Serghei Cebotari
Journal:  Eur J Cardiothorac Surg       Date:  2016-03-24       Impact factor: 4.191

4.  Medium term follow-up after percutaneous pulmonary valve replacement with the Melody® valve.

Authors:  Bjorn Cools; Werner Budts; Ruth Heying; Derize Boshoff; Benedicte Eyskens; Stefan Frerich; Els Troost; Marc Gewillig
Journal:  Int J Cardiol Heart Vasc       Date:  2015-03-06

Review 5.  Current development of bovine jugular vein conduit for right ventricular outflow tract reconstruction.

Authors:  Chenggang Li; Bo Xie; Ruizhe Tan; Lijin Liang; Zhaoxiang Peng; Qi Chen
Journal:  Front Bioeng Biotechnol       Date:  2022-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.